EntryPoint Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$253K	Sell	11,666 -449	-4%	-$9.74K	0.13%	369
2025 Q1	$294K	Buy	+12,115	New	+$294K	0.13%	330
2024 Q1	–	Sell	-11	Closed	-$185	–	1479
2023 Q4	$185	Buy	+11	New	+$185	﹤0.01%	1307